Federal Register / Vol. 80, No. 10 / Thursday, January 15, 2015 / Notices 2115 

Group; Respiratory Integrative Biology and 

Translational Research Study Section. 

Date: February 12–13, 2015. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Pier 5 Hotel, 711 Eastern Avenue, 

Baltimore, MD 21202. 

Contact Person: Bradley Nuss, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4142, 

MSC7814, Bethesda, MD 20892, 301–451– 

8754, nussb@csr.nih.gov. 

Name of Committee: Infectious Diseases 

and Microbiology Integrated Review Group; 

Pathogenic Eukaryotes Study Section. 

Date: February 12–13, 2015. 

Time: 8:30 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Best Western Tuscan Inn, 425 North 

Point Street, San Francisco, CA 94133. 

Contact Person: Tera Bounds, DVM, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3198, 

MSC 7808, Bethesda, MD 20892, 301 435– 

2306, boundst@csr.nih.gov. 

Name of Committee: Infectious Diseases 

and Microbiology Integrated Review Group; 

Clinical Research and Field Studies of 

Infectious Diseases Study Section. 

Date: February 12–13, 2015. 

Time: 8:30 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Residence Inn Duke Street, 1456 

Duke Street, Alexandria, VA 22314. 

Contact Person: Soheyla Saadi, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3211, 

MSC 7808, Bethesda, MD 20892, 301–435– 

0903, saadisoh@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Enabling 

Bioanalytical and Imaging Technologies. 

Date: February 13, 2015. 

Time: 8:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Renaissance Arlington Capital View 

Hotel, Arlington, VA 22202. 

Contact Person: Maria DeBernardi, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6158, 

MSC 7892, Bethesda, MD 20892, 301–435– 

1355, debernardima@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: January 9, 2015. 

Anna Snouffer, 

Deputy Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2015–00495 Filed 1–14–15; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review: Amended 

Notice of Meeting 

Notice is hereby given of a change in 

the meeting of the Sensorimotor 

Integration Study Section, February 06, 

2015, 08:00 a.m. to February 06, 2015, 

06:00 p.m., JW Marriott New Orleans, 

614 Canal Street, New Orleans, LA, 

70130 which was published in the 

Federal Register on January 08, 2015, 80 

FR 1031. 

The meeting will be held at the 

Renaissance New Orleans Pere 

Marquette Hotel, 817 Common Street 

New Orleans, LA, 70112. The meeting 

date and time remain the same. The 

meeting is closed to the public. 

Dated: January 8, 2015. 

Carolyn A. Baum, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2015–00496 Filed 1–14–15; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Drug Abuse; 

Notice of Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of a meeting of the 

National Advisory Council on Drug 

Abuse. 

The meeting will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications 

and/or contract proposals and the 

discussions could disclose confidential 

trade secrets or commercial property 

such as patentable material, and 

personal information concerning 

individuals associated with the grant 

applications and/or contract proposals, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Advisory 

Council on Drug Abuse. 

Date: February 3, 2015. 

Closed: 8:30 a.m. to 10:00 a.m. 

Agenda: To review and evaluate grant 

applications and/or proposals. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Conference Rooms C & D, 

Rockville, MD 20852. 

Open: 10:15 a.m. to 4:00 p.m. 

Agenda: This portion of the meeting will 

be open to the public for announcements and 

reports of administrative, legislative, and 

program developments in the drug abuse 

field. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Conference Rooms C & D, 

Rockville, MD 20852. 

Contact Person: Susan R.B. Weiss, Ph.D., 

Director, Division of Extramural Research, 

Office of the Director, National Institute on 

Drug Abuse, NIH, DHHS, 6001 Executive 

Boulevard, NSC, Room 5274, MSC 9591, 

Rockville, MD 20892, 301–443–6487, 

sweiss@nida.nih.gov. 

Any member of the public interested in 

presenting oral comments to the committee 

may notify the Contact Person listed on this 

notice at least 10 days in advance of the 

meeting. Interested individuals and 

representatives of organizations may submit 

a letter of intent, a brief description of the 

organization represented, and a short 

description of the oral presentation. Only one 

representative of an organization may be 

allowed to present oral comments and if 

accepted by the committee, presentations 

may be limited to five minutes. Both printed 

and electronic copies are requested for the 

record. In addition, any interested person 

may file written comments with the 

committee by forwarding their statement to 

the Contact Person listed on this notice. The 

statement should include the name, address, 

telephone number and when applicable, the 

business or professional affiliation of the 

interested person. 

Information is also available on the 

Institute’s/Center’s home page: 

www.drugabuse.gov/NACDA/

NACDAHome.html, where an agenda and 

any additional information for the meeting 

will be posted when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos.: 93.279, Drug Abuse and 

Addiction Research Programs, National 

Institutes of Health, HHS) 

Dated: January 9, 2015. 

Michelle Trout, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2015–00487 Filed 1–14–15; 8:45 am] 

BILLING CODE 4140–01–P 


rljohnson on DSK3VPTVN1PROD with NOTICES